Federal contract award
47QFLA25F0060
TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | General Services Administration |
| Office | GSA FAS AAS REGION 5 |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AC12 — NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH |
| Parent award / vehicle | 47QFLA21D0018 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $33.5M |
| Current contract value | $36.2M |
| Potential contract value / ceiling | $58.4M |
| Start date | Jun 30, 2025 |
| Current end date | Jun 29, 2027 |
| Potential end date | Sep 20, 2029 |
| Latest award activity | Aug 31, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 31, 2026 | P00011 | $16.1M | TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR - REALIGN CEILING AND ADD FUNDING |
| Jun 26, 2026 | P00010 | $946.3K | TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR - EXERCISE OY1 |
| Jun 25, 2026 | P00009 | $0 | TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR - FUNDING REALIGNMENT |
| Apr 16, 2026 | P00008 | $131.1K | TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR, INCREMENTAL FUNDING MODIFICATION |
| Apr 10, 2026 | P00007 | $0 | TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR - FUNDING REALIGNMENT |
| Mar 11, 2026 | P00006 | $48.5K | TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR - REALIGN CEILING AND FUNDING |
| Mar 4, 2026 | P00005 | $1.2M | TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR - INCREMENTAL FUNDING |
| Dec 18, 2025 | P00004 | $4.5M | TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR, INCREMENTAL FUNDING MODIFICATION |
| Oct 22, 2025 | P00003 | $0 | TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR - FPDS ENTITY INFORMATION UPDATE |
| Sep 24, 2025 | P00002 | $8.5M | TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR. THIS MODIFICATION REALIGNS $200,000 IN CEILING VALUE FROM CLIN 0001 LABOR TO CLIN 0002 TRAVEL. IT ALSO ADDS INCREMENTAL FUNDING IN THE AMOUNT OF $8,450,549.53. |
| Aug 27, 2025 | P00001 | $985.4K | TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR, INCREMENTAL FUNDING. |
| Jun 27, 2025 | 0 | $1.2M | TO05 RESILIENCE AND ASSURANCE FOR MISSION EFFECTIVENESS AND C4ISR |
Estimated positioning window
Sep 20, 2028 – Mar 20, 2029
65/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 65/100. Available recorded signals: 60 points.
- Contract end 2029-09-20 (1061 days from calculation)
- +15 points
- 45 historical awards in this buyer and category group
- +15 points
- 12 recorded award transactions
- +10 points
- Latest award action: 2026-08-31
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.